Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells

BACKGROUND: Resistance to human epidermal growth factor receptor-2 (HER2)-targeted therapies is common, and results in treatment failure and new tumor progression. C35 is over-expressed in many invasive breast cancer endogenously, and functions as an oncogene in breast cancer cell lines. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Che, Wen, Bao, Yun, Tang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578656/
https://www.ncbi.nlm.nih.gov/pubmed/28859163
http://dx.doi.org/10.1371/journal.pone.0183941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578656/
https://www.ncbi.nlm.nih.gov/pubmed/28859163
http://dx.doi.org/10.1371/journal.pone.0183941

Ejemplares similares